BP
OCUL icon

Ballentine Partners’s Ocular Therapeutix OCUL Stock Holding History

Ballentine Partners’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-210,001
Closed -$8.82M – 160
2015
Q1 		$8.82M Buy
+210,001
New +$8.82M 0.87% 19